CBD And Schizophrenia

By | CBD, Research Articles, Schizophrenia

CBD for Schizophrenia | Schizophrenia CBD Treatments

CBD for Schizophrenia: This recent article in the March, 2012 issue of Translational Psychiatry reports on a double-blind, randomized clinical trial of cannabidiol vs amisulpride, a potent antipsychotic, in acute schizophrenia to evaluate the clinical relevance of initial findings. Either treatment was safe and led to significant clinical improvement, but cannabidiol displayed a markedly superior side effect profile. Read More

CBD & Chemotherapy Induced Neuropathy

By | Cancer, CBD, Neuropathy, Research Articles

CBD for Chemotherapy Induced Neuropathy | CBD and Chemotherapy

Taxol is a common chemotherapy agent that is a mitotic inhibitor. It is used to treat patients with lung, ovarian, breast, head & neck cancer and advanced forms of Kaposi’s sarcoma. One of the painful side effects of this agent is neuropathy, a side effect that can limit the effective use of the drug. This article shows promise in using CBD to help prevent the neuropathy caused by Taxol. Read More

SCC Hears McAllister On Cannabis Cancer Research

By | Cancer, CBD, Research Articles

SCC Hears McAllister On Cannabis Cancer ResearchSean McAllister, PhD, who has been studying the anti-cancer effects of cannabinoids in the laboratory (on a grant from NIH and with a license from the DEA). The occasion was the winter meeting of the Society of Cannabis Clinicians.”That’s a very good question,” McAllister would say…and provide the answer, and tie it back into his main thread. Read More